Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nina L. Hunter"'
Autor:
Nina L. Hunter, Rachel E. Sherman, Michael J. Rappel, Kyle O. Hair, Robert M. Califf, April I. Alexandrow
Publikováno v:
Clinical and Translational Science. 10:124-127
Therapeutics known as combination products because they combine drug, device, and/or biologic elements can offer important advantages relative to single‐modality products. However, regulatory policy in this arena has lagged relative to increases in
Publikováno v:
Nature reviews. Drug discovery. 16(11)
Scientific advances, in combination with government incentives and commercial opportunity, have fuelled strong investment in orphan drugs, resulting in many innovative therapies. Here, we discuss the approach of the FDA to a range of issues that rema
Publikováno v:
Nature reviews. Drug discovery. 16(5)
Growing access to diverse 'real-world' data sources is enabling new approaches to close persistent evidence gaps about the optimal use of medical products in real-world practice. Here, we argue that contrary to widespread impressions, existing FDA re
Autor:
Danica Marinac-Dabic, Thomas G. Gross, Lisa M. LaVange, Gerry W. Gray, Lilly Q. Yue, Robert Temple, Jeffrey Shuren, Janet Woodcock, Steven A. Anderson, Melissa A. Robb, Nina L. Hunter, Robert M. Califf, Peter W. Marks, Gerald J. Dal Pan, Rachel E. Sherman
Publikováno v:
The New England journal of medicine. 375(23)
The FDA is developing guidance on the use of “real-world evidence” — health care information from atypical sources, including electronic health records, billing databases, and product and disease registries — to assess the safety and effectiv
Autor:
Rachel E. Sherman, Nina L. Hunter
Publikováno v:
Nature Reviews Drug Discovery. 16:513-514
New opportunities to develop innovative — and often complex — products that combine drugs, devices and/or biological components are rapidly emerging, raising questions about how such products should be regulated. Here, we discuss the ongoing effo
Publikováno v:
JAMA. 314(23)
Publikováno v:
Developmental Dynamics. 235:279-284
Frodo has been identified as a protein interacting with Dishevelled, an essential mediator of the Wnt signaling pathway, critical for the determination of cell fate and polarity in embryonic development. In this study, we use specific gene probes to
Autor:
Nina L. Hunter, Susan M. Dymecki
Publikováno v:
Development (Cambridge, England). 134(19)
Both hindbrain roof plate epithelium (hRPe) and hindbrain choroid plexus epithelium (hCPe) produce morphogens and growth factors essential for proper hindbrain development. Despite their importance, little is known about how these essential structure
Autor:
Amna Ibrahim, Nina L. Hunter, Robert Justice, Julia A. Beaver, Todd R. Palmby, Patricia Cortazar, Richard Pazdur, Gideon M. Blumenthal
Publikováno v:
Journal of Clinical Oncology. 32:e22181-e22181
e22181 Background: The development of targeted therapies for cancer has thrived with improved understanding of genetic mechanisms and co-development of companion diagnostics. Methods: Clinical tria...
Publikováno v:
Genesis: The Journal of Genetics & Development; Mar2005, Vol. 41 Issue 3, p99-109, 11p